Dupi Effect on Airway Hyper-Responsiveness and Lung Function in Severe Asthma
The following is a summary of “Effects of dupilumab on mannitol airway hyperresponsiveness in...
Read MoreNov 28, 2024
The following is a summary of “Effects of dupilumab on mannitol airway hyperresponsiveness in...
Read MoreNov 25, 2024
The following is a summary of “Effect of Mepolizumab in airway’s remodelling in patients with...
Read MoreSep 11, 2024
The following is a summary of “Choosing the right biologic treatment for individual patients with...
Read MoreAug 3, 2024
The incremental step test (IST) reliably, conveniently, and cost-effectively assesses exercise capacity in moderate-to-severe asthma.
Read MoreJul 12, 2024
The following is a summary of “Dupilumab responder types and predicting factors in patients with...
Read MoreJun 21, 2024
Severe asthma presents a significant clinical challenge, marked by heightened exacerbation risk, diminished lung function, fixed airflow obstruction, and substantial morbidity and mortality. As new therapies increasingly target...
Read MoreJun 4, 2024
The following is a summary of “A survey of severe asthma in Canada: results from the CASCADE...
Read MoreMay 30, 2024
The following is a summary of “Clinical Characteristics and Impact of Inducible Laryngeal...
Read MoreMay 29, 2024
The following is a summary of “Core Function in Adults With Severe Asthma and Its...
Read MoreMay 24, 2024
THURSDAY, May 23, 2024 (HealthDay News) — Only 14.5 percent of adult patients with moderate...
Read MoreMay 9, 2024
The following is a summary of “Long-Term Safety of Dupilumab in Patients With...
Read MoreMay 9, 2024
The following is a summary of “Burden of Uncontrolled Severe Asthma With and Without...
Read MoreMay 7, 2024
The following is a summary of “Barriers to clinical remission in severe asthma,” published in the...
Read MoreMay 5, 2024
The following is a summary of “Ventilation Heterogeneity Is a Treatable Trait in Severe...
Read MoreApr 17, 2024
TUESDAY, April 16, 2024 (HealthDay News) — The U.S. Food and Drug Administration has...
Read MoreMar 12, 2024
The following is a summary of “Comparison of clinical remission criteria for severe asthma...
Read MoreMar 12, 2024
The following is a summary of “Airway wall extracellular matrix changes induced by bronchial...
Read MoreFeb 20, 2024
The following is a summary of “Phenotyping of Severe Asthma in the Era of Broad-acting Anti-asthma...
Read MoreFeb 20, 2024
The following is a summary of “Real-life studies and registries of severe asthma: The advent...
Read MoreJan 29, 2024
Severe asthma is associated with significant morbidity and mortality despite maximal use of inhaled corticosteroids and additional controller medications, and has a high economic burden. Biologic therapies are recommended for...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.